Improvement of drug therapy safety for oncological patients in the inpatient sector by a pharmacist embedded in a multiprofessional healthcare team.
Not Applicable
- Conditions
- medication errors
- Registration Number
- DRKS00026729
- Lead Sponsor
- Klinikum Fulda gAG
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 148
Inclusion Criteria
Patients diagnosed with C00-D48 or D50-D90.
Patients of the tumor clinic of the Fulda Clinic gAG.
Ward stay = 72 h. P2: ward pharmacist naive for six months before starting P2.
Exclusion Criteria
No saved temperature curve (incomplete documentation).
< six medication lines per stay.
Patients are not cared for by an oncologist.
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Reduction of medication errors through the work of a ward pharmacist.
- Secondary Outcome Measures
Name Time Method Reduction of quantity / costs for selected drugs (excluding chemotherapeutic agents and antibodies). <br>Time savings on the ward by working according to standards in the various intervention phases. <br>Compliance with developed / existing therapy standards.